Amanda Mohr

TitleInstructor ETO
InstitutionThomas Jefferson University
DepartmentJefferson College of Life Scie
Address1020 Locust St.
Philadelphia PA 19107
Phone215-366-1591
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mohr A, de Souza Barbosa F, Wingert NR, Takeuchi CK, Garcia L, Ribeiro MFN, Arbo MD, de Oliveira TF, Steppe M. Analysis of omarigliptin forced degradation products by ultra-fast liquid chromatography, mass spectrometry, and in vitro toxicity assay. Biomed Chromatogr. 2024 May 29; e5904. PMID: 38811368.
      Citations:    
    2. Cieri G, Mohr ALA, Mastrovito R, Logan BK. Evaluating cross-reactivity of new psychoactive substances (NPS) in human whole blood by enzyme-linked immunosorbent assay (ELISA). J Anal Toxicol. 2024 Feb 28. PMID: 38456706.
      Citations:    
    3. Kacinko SL, Mohr ALA, Logan BK, Barbieri EJ. Xylazine: Pharmacology Review and Prevalence and Drug Combinations in Forensic Toxicology Casework. J Anal Toxicol. 2022 Oct 14; 46(8):911-917. PMID: 35770859.
      Citations:    
    4. Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. J Anal Toxicol. 2022 Jul 14; 46(6):e116-e185. PMID: 35445267.
      Citations:    
    5. Rodriguez Salas J, Krotulski AJ, Newman R, Thogmartin JR, Mohr ALA, Logan BK. Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations. J Anal Toxicol. 2022 Apr 21; 46(4):358-373. PMID: 33693685.
      Citations:    
    6. Fogarty MF, Mohr ALA, Papsun DM, Logan BK. Analysis of the Illicit Opioid U-48800 and Related Compounds by LC-MS-MS and Case Series of Fatalities Involving U-48800. J Anal Toxicol. 2022 Feb 14; 46(1):17-24. PMID: 33237987.
      Citations:    
    7. Krotulski AJ, Garibay N, Walther D, Walton SE, Mohr ALA, Logan BK, Baumann MH. Pharmacokinetics and pharmacodynamics of the synthetic cannabinoid, 5F-MDMB-PICA, in male rats. Neuropharmacology. 2021 11 01; 199:108800. PMID: 34547333.
      Citations:    
    8. D'Orazio AL, Mohr ALA, Chan-Hosokawa A, Harper C, Huestis MA, Limoges JF, Miles AK, Scarneo CE, Kerrigan S, Liddicoat LJ, Scott KS, Logan BK. Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities-2021 Update. J Anal Toxicol. 2021 Jul 10; 45(6):529-536. PMID: 34086916.
      Citations:    
    9. Mohr ALA, Fogarty MF, Krotulski AJ, Logan BK. Evaluating Trends in Novel Psychoactive Substances Using a Sentinel Population of Electronic Dance Music Festival Attendees. J Anal Toxicol. 2021 May 14; 45(5):490-497. PMID: 32860703.
      Citations:    
    10. Krotulski AJ, Bishop-Freeman SC, Mohr ALA, Logan BK. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment. J Anal Toxicol. 2021 Feb 06; 45(1):60-68. PMID: 32435808.
      Citations:    
    11. Norman C, Halter S, Haschimi B, Acreman D, Smith J, Krotulski AJ, Mohr ALA, Logan BK, NicDa?id N, Auw?rter V, McKenzie C. A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations. Drug Test Anal. 2021 Apr; 13(4):841-852. PMID: 33463894.
      Citations:    
    12. Baumann MH, Tocco G, Papsun DM, Mohr AL, Fogarty MF, Krotulski AJ. U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market. Brain Sci. 2020 Nov 23; 10(11). PMID: 33238449.
      Citations:    
    13. Krotulski AJ, Mohr ALA, Logan BK. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection. J Anal Toxicol. 2020 Apr 30; 44(3):207-217. PMID: 31909808.
      Citations:    
    14. Krotulski AJ, Mohr ALA, Diamond FX, Logan BK. Detection and characterization of the new synthetic cannabinoid APP-BINACA in forensic casework. Drug Test Anal. 2020 Jan; 12(1):136-144. PMID: 31788963.
      Citations:    
    15. Cannaert A, Deventer M, Fogarty M, Mohr ALA, Stove CP. Hide and Seek: Overcoming the Masking Effect of Opioid Antagonists in Activity-Based Screening Tests. Clin Chem. 2019 12; 65(12):1604-1605. PMID: 31575612.
      Citations:    
    16. Krotulski AJ, Mohr ALA, Kacinko SL, Fogarty MF, Shuda SA, Diamond FX, Kinney WA, Menendez MJ, Logan BK. 4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework. J Forensic Sci. 2019 Sep; 64(5):1451-1461. PMID: 31260580.
      Citations:    
    17. Krotulski AJ, Mohr ALA, Fogarty MF, Logan BK. The Detection of Novel Stimulants in Oral Fluid from Users Reporting Ecstasy, Molly and MDMA Ingestion. J Anal Toxicol. 2018 Oct 01; 42(8):544-553. PMID: 30371847.
      Citations:    
    18. Krotulski AJ, Mohr ALA, Papsun DM, Logan BK. Dibutylone (bk-DMBDB): Intoxications, Quantitative Confirmations and Metabolism in Authentic Biological Specimens. J Anal Toxicol. 2018 Sep 01; 42(7):437-445. PMID: 29554274.
      Citations:    
    19. Krotulski AJ, Papsun DM, De Martinis BS, Mohr ALA, Logan BK. N-Ethyl Pentylone (Ephylone) Intoxications: Quantitative Confirmation and Metabolite Identification in Authentic Human Biological Specimens. J Anal Toxicol. 2018 Sep 01; 42(7):467-475. PMID: 29618077.
      Citations:    
    20. Cannaert A, Vasudevan L, Friscia M, Mohr ALA, Wille SMR, Stove CP. Activity-Based Concept to Screen Biological Matrices for Opiates and (Synthetic) Opioids. Clin Chem. 2018 08; 64(8):1221-1229. PMID: 29776952.
      Citations:    
    21. Krotulski AJ, Mohr ALA, Friscia M, Logan BK. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere? DDS?2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS). J Anal Toxicol. 2018 Apr 01; 42(3):170-176. PMID: 29301050.
      Citations:    
    22. Logan BK, D'Orazio AL, Mohr ALA, Limoges JF, Miles AK, Scarneo CE, Kerrigan S, Liddicoat LJ, Scott KS, Huestis MA. Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities-2017 Update. J Anal Toxicol. 2018 Mar 01; 42(2):63-68. PMID: 29186455.
      Citations:    
    23. Mohr ALA, Friscia M, Yeakel JK, Logan BK. Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees. Forensic Sci Int. 2018 Jan; 282:168-178. PMID: 29216523.
      Citations:    
    24. Logan BK, Mohr ALA, Friscia M, Krotulski AJ, Papsun DM, Kacinko SL, Ropero-Miller JD, Huestis MA. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review. J Anal Toxicol. 2017 Sep 01; 41(7):573-610. PMID: 28459969.
      Citations:    
    25. Temporal KH, Scott KS, Mohr ALA, Logan BK. Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine. J Anal Toxicol. 2017 Sep 01; 41(7):646-657. PMID: 28472358.
      Citations:    
    26. Papsun D, Hawes A, Mohr ALA, Friscia M, Logan BK. Case Series of Novel Illicit Opioid-Related Deaths. Acad Forensic Pathol. 2017 Sep; 7(3):477-486. PMID: 31239996.
      Citations:    
    27. Krotulski AJ, Mohr ALA, Papsun DM, Logan BK. Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users. Drug Test Anal. 2018 Jan; 10(1):127-136. PMID: 28608586.
      Citations:    
    28. Mohr AL, Friscia M, Papsun D, Kacinko SL, Buzby D, Logan BK. Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework. J Anal Toxicol. 2016 Nov; 40(9):709-717. PMID: 27590036.
      Citations:    
    29. Logan BK, Mohr AL, Talpins SK. Response to "Comparison of urine to oral fluid and the recommendation for routine drug analysis for driving under the influence cases". J Anal Toxicol. 2015 May; 39(4):332-3. PMID: 25698776.
      Citations:    
    30. Mohr AL, Ofsa B, Keil AM, Simon JR, McMullin M, Logan BK. Enzyme-linked immunosorbent assay (ELISA) for the detection of use of the synthetic cannabinoid agonists UR-144 and XLR-11 in human urine. J Anal Toxicol. 2014 Sep; 38(7):427-31. PMID: 24908262.
      Citations:    
    31. Logan BK, Mohr AL, Talpins SK. Detection and prevalence of drug use in arrested drivers using the Dr?ger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices. J Anal Toxicol. 2014 Sep; 38(7):444-50. PMID: 24894458.
      Citations:    
    Mohr's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (108)
    Explore
    _
    Co-Authors (5)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _